Clinical Trials Directory

Trials / Completed

CompletedNCT03817333

The Mixed Phenotype of Asthma and COPD: the Overlap Syndrome

The Mixed Phenotype of Asthma and COPD: the Overlap Syndrome: A Comparison of Asthma Outcomes in Smoking vs Non-smoking Patients With an Incomplete Reversibility of Airway Obstruction (IRAO)

Status
Completed
Phase
Study type
Observational
Enrollment
115 (actual)
Sponsor
Laval University · Academic / Other
Sex
All
Age
45 Years
Healthy volunteers
Not accepted

Summary

RATIONALE: In asthmatic subjects, smoking can lead to several changes in disease characterictics. in smokers of more than 20 pack-years, chronic obstructive pulmonary disease (COPD) can be associated with asthma, also called asthma-COPD overlap syndrome (ACOS). Increasing data support the concept that ACOS is a clinical entity. However, this should be further studied in order to better target therapy. AIM: The objective of this study is to evaluate the comparative features of ACOS METHODS: This will be a descriptive study comparing the features of the ACOS with the features of asthmatic subjects with an incomplete reversibility of airway obstruction (IRAO).The study will be done over 1 or 2 visits (within a week interval), according to subjects' availability. The visit will include completion of different questionnaires (asthma control asthma quality of life, medical history, exacerbations, etc.), a thoracic examination, allergy skin-prick tests, spirometry and bronchodilator response, lung volumes and compliance measurements, exhaled nitric oxide measurement, blood sampling and a sputum induction.

Conditions

Timeline

Start date
2014-03-01
Primary completion
2016-12-01
Completion
2017-12-01
First posted
2019-01-25
Last updated
2019-01-25

Locations

1 site across 1 country: Canada

Source: ClinicalTrials.gov record NCT03817333. Inclusion in this directory is not an endorsement.